I want to pursue a graduate program in Biotechnology at the University of Toronto and eventually become a professor in the field of Biopharmaceutical and Digital Health Technology. My research interest includes Drug Manufacturing, Protein Chemistry & Technological Innovation.
I gained my bachelor’s degree in Biochemistry at Purdue University, America. As part of my research, I published a paper with Technology Review titled – The increasing importance of precision and personalized medicine in the treatment of cancer.
The use of precision and personalized medicine (PPM) and its effects on addressing the complexity of cancer treatment are the main topics of my research paper. PPM in cancer patients is mostly caused by underlying genetic factors and protein variation. As a result, it is impossible to treat all cancer patients using the same method. Regulatory organizations are now acknowledging that PPM, which avoids genetics, is more beneficial for cancer patients.
After completing my undergraduate degree, I worked in the company for six years, gaining knowledge in radioisotope use, protein purification, pharmacokinetics, and in vivo drug metabolism. As a Research Volunteer in Drug Design at the National Biotechnology Conference, I assist in providing research and clinical trial for patients.
My general research area is Human Drug Manufacturing. I want to continue developing cutting-edge drugs with the use of technology, especially for people who are terminally ill. This will help those who are diagnosed early and allow relatives and friends of terminally ill patients to spend as much time with the patient as possible.
If admitted, I plan to work with Dr John Dwyer, in the field of Biopharmaceutical. I want to collaborate with him to develop pharmaceuticals to help terminally ill individuals, like how my undergraduate research thesis focused on treatment for patients with the life-threatening illness.
Thank you for your consideration.